Adcytherix Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $32.5M

  • Investors
  • 6

Adcytherix General Information

Description

Operator of a biopharmaceutical company intended to develop novel antibody drug conjugates to treat cancer. The company offers drugs to treat unmet-need diseases, enabling healthcare industries to improve patient treatment and outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17 Boulevard Augustin Cieussa
  • 13007 Marseille
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 17 Boulevard Augustin Cieussa
  • 13007 Marseille
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adcytherix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 11-Jun-2024 $32.5M Completed Generating Revenue
To view Adcytherix’s complete valuation and funding history, request access »

Adcytherix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to develop novel antibody drug conjugates to treat cancer. The company
Drug Discovery
Marseille, France
10 As of 2025

San Carlos, CA
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adcytherix Competitors (46)

One of Adcytherix’s 46 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iovance Biotherapeutics Corporation San Carlos, CA
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Meditope Biosciences Venture Capital-Backed Pasadena, CA
Cantex Pharmaceuticals Formerly VC-backed Weston, FL
You’re viewing 5 of 46 competitors. Get the full list »

Adcytherix Patents

Adcytherix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024210894-A1 Ecteinascidin derivative antibody drug conjugates Pending 17-Jan-2023

Adcytherix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adcytherix Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dawn Biopharma Corporation Minority
Kinled Holding Family Office Minority
Pontifax Venture Capital Venture Capital Minority
Pureos Bioventures Venture Capital Minority
RA Capital Management Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Adcytherix FAQs

  • When was Adcytherix founded?

    Adcytherix was founded in 2024.

  • Where is Adcytherix headquartered?

    Adcytherix is headquartered in Marseille, France.

  • What is the size of Adcytherix?

    Adcytherix has 10 total employees.

  • What industry is Adcytherix in?

    Adcytherix’s primary industry is Drug Discovery.

  • Is Adcytherix a private or public company?

    Adcytherix is a Private company.

  • What is the current valuation of Adcytherix?

    The current valuation of Adcytherix is .

  • What is Adcytherix’s current revenue?

    The current revenue for Adcytherix is .

  • How much funding has Adcytherix raised over time?

    Adcytherix has raised $32.5M.

  • Who are Adcytherix’s investors?

    Dawn Biopharma, Kinled Holding, Pontifax Venture Capital, Pureos Bioventures, and RA Capital Management are 5 of 6 investors who have invested in Adcytherix.

  • Who are Adcytherix’s competitors?

    Iovance Biotherapeutics, Oxford Biotherapeutics, CytomX Therapeutics, Meditope Biosciences, and Cantex Pharmaceuticals are some of the 46 competitors of Adcytherix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »